. Spearman correlation coefficients among prenatal plasma PFAS concentrations (ng/mL) and maternal (n=732) and neonatal (n=480) thyroid hormones. Table S2 . Prenatal plasma PFAS concentration (ng/mL) distributions in the excluded Project Viva participants (n=913). Table S3 . Adjusted difference in maternal thyroid hormone levels per quartile (Q2-4 vs. Q1) of plasma PFAS concentrations (n=726). Table S4 . Adjusted difference in neonatal T 4 (µg/dL) per quartile (Q2-4 vs. Q1) of plasma PFAS concentrations in all neonates and stratified by sex. Table S5 . Adjusted difference in neonatal T 4 (µg/dL) per IQR increase in prenatal plasma PFAS concentrations in all neonates and stratified by sex -sensitivity analysis results. Table S6 . Prenatal plasma PFAS distributions by maternal TPOAb status (n=732).
. Spearman correlation coefficients among prenatal plasma PFAS concentrations (ng/mL) and maternal (n=732) and neonatal (n=480) thyroid hormones. Table S2 . Prenatal plasma PFAS concentration (ng/mL) distributions in the excluded Project Viva participants (n=913). Table S3 . Adjusted difference in maternal thyroid hormone levels per quartile (Q2-4 vs. Q1) of plasma PFAS concentrations (n=726). Table S4 . Adjusted difference in neonatal T 4 (µg/dL) per quartile (Q2-4 vs. Q1) of plasma PFAS concentrations in all neonates and stratified by sex. Table S5 . Adjusted difference in neonatal T 4 (µg/dL) per IQR increase in prenatal plasma PFAS concentrations in all neonates and stratified by sex -sensitivity analysis results. PFOS, 0.31, 0.13, 0.29; PFOA, 0.40, 0.20, 0.32; PFHxS, 0.16, 0.16, 0.01; PFNA, 0.10, 0.39, 0.11; EtFOSAA, 0.36, 0.23, 0.39; MeFOSAA, 0.22, 0.15, 0.40 .25) a Adjusted for maternal age, race/ethnicity, smoking status, parity, gestational week at maternal blood draw, child sex, cesarean delivery, gestational age, and age at heel stick b All n=465; male n=236; female n=229 c Adjusted for maternal age, race/ethnicity, smoking status, parity, gestational week at maternal blood draw, child sex, and age at heel stick (All n=465; male n=236; female n=229) d Restricted to neonates with heel sticks ≥ 2 days postpartum (all n=175; male n=89; female n=86) e Restricted to neonates with gestational age ≥ 37 weeks (all n=437; male n=219; female n=218) f Additionally adjusted for maternal total T4, Free T4 Index, and TSH levels (all n=456; male n=231; female n=225) g Models additionally adjusted for infant sex 
